In the face of such pressure, pharmaceutical companies are eager to reduce the cost of drug development so that consumer prices can be lowered without sacrificing profit margin. Fortunately ...

However, as groundbreaking as these therapies are, they also pose unique challenges for the drug development process, particularly regarding quality assurance (QA). The role of QA is more critical ...

Scientists discover a 'Goldilocks' zone for DNA organization, opening new doors for drug development. ScienceDaily . Retrieved December 31, 2024 from www.sciencedaily.com / releases / 2024 / 12 ...

The groundbreaking development of a Japanese drug aimed at regrowing teeth has launched worldwide excitement. This innovative approach, currently entering clinical trials, has the potential to ...

There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.

After two decades of experience with biosimilars, physicochemical and in vitro biological comparison with their reference products appear sufficient to guarantee clinical safety and efficacy.

Additionally, since more of our patients with ILD events had been treated with bucillamine than those without ILD events, a prospective re-evaluation would verify our data and match patients’ ...

Explore the benefits for developers and IT managers alike. Organizations around the world are accelerating their development cycles and tapping into new wells of innovation within their companies ...

Approximately 9.5% (US$15.7 million) of global funding was focused on drug development, a 106% increase from even 2008, and a step in the right direction considering this amount is three times the ...

Stromal cells contained within the PDA tumour microenvironment therefore represent an additional constituent to neoplastic cells that should be critically evaluated for optimal therapeutic development ...

Remote intervention has been performed successfully for percutaneous coronary intervention17 and coronary stenting,18 but still requires significant development for neurointerventional procedures.

All children are individual and develop at different rates. In this toolkit there is a lot of information about typical development and developmental milestones and it is important to remember is that ...